Immusoft

Immusoft

Immusoft

Immusofts mission is to develop a completely new platform for delivering medicines programming a patients own cells to become miniature drug factories.
Type
B2c
Founded
2009
Raised
$30.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$4,500,000
Venture capital - 2020
Mesa Verde Venture Partners Breakout Ventures Ikarian Capital
Team Size
10+
Employees
$4,500,000 Venture capital
GeekWire

Seattle gene therapy biotech startup Immusoft raises $4.5M

Xconomy

Seattle Startup Funding News: Immusoft, TurboPatent, VYRTY & More

$20,000,000 Venture capital (Series B)
FinSMEs , PE HUB , GeekWire , +1

Immusoft Raises $20M in Series B Financing

$3,000,000 Venture capital (Series B)
GeekWire

Gene therapy startup Immusoft raises $3M, appoints new CEO as it approaches clinical trials

Science Health Strategy
$2,700,000 Venture capital (Series A)
Immusoft Corporation , Immusoft Corporation

http://immusoft.com/wp-content/uploads/2016/11/Immusoft-Closes-Round-Nov-2016.pdf

Acquisition
GeekWire

Gene therapy biotech startup Immusoft acquires Discovery Genomics

Science Health